河北医科大学学报 ›› 2024, Vol. 44 ›› Issue (5): 524-529.doi: 10.3969/j.issn.1007-3205.2024.05.006

• • 上一篇    下一篇

新生儿呼吸窘迫综合征无创经皮血气+体位管理+保护性通气前后MMP-16、Claudin-18、CC16变化及与并发支气管肺发育不良的相关性

  

  1. 河北省衡水市第二人民医院儿科,河北 衡水 053000

  • 出版日期:2024-05-25 发布日期:2024-05-22
  • 作者简介:田金凤(1989-),女,河北衡水人,河北省衡水市第二人民医院主治医师,医学学士,从事儿科疾病诊治研究。
  • 基金资助:
    衡水市科技计划项目(2022014086Z)

Changes in MMP-16, Claudin-18 and CC16 before and after non-invasive transcutaneous blood gas+postural management+protective ventilation in neonatal respiratory distress syndrome and their correlation with concurrent BPD

  1. Department of Pediatrics, the Second People′s Hospital of Hengshui City, Hebei Province, Hengshui 053000, China

  • Online:2024-05-25 Published:2024-05-22

摘要: 目的 探讨无创经皮血气+体位管理+保护性通气干预新生儿呼吸窘迫综合征对患儿基质金属蛋白酶16(matrix metalloproteinase 16,MMP-16)、紧密连接蛋白18(Claudin 18 protein ,Claudin-18)和Clara细胞分泌蛋白16(Clara cell secretes protein 16,CC16)的影响,并分析上述指标与支气管肺发育不良(bronchopulmonary dysplasia,BPD)的相关性。
方法 前瞻性选取呼吸窘迫综合征新生儿106例为研究对象,所有患儿均接受无创经皮血气+体位管理+保护性通气干预,观察患儿干预前后MMP-16、Claudin-18、CC16变化。统计患儿2周内BPD发生状况,并将其分为BPD组与非BPD组,分析MMP-16、Claudin-18、CC16与BPD发生的关系。
结果 干预后,MMP-16水平低于干预前,Claudin-18、CC16水平高于干预前(P<0.05);106例呼吸窘迫综合征患儿中发生BPD 57例,占53.77%;与非BPD组相比,BPD组MMP-16水平更高,Claudin-18、CC16水平更低(P<0.05);经点二列相关性分析,结果显示,MMP-16与BPD发生呈正相关(r=0.542,P<0.05),Claudin-18、CC16水平与BPD发生呈负相关(r=-0.526,-0.639,P<0.05);经Logistic回归分析,结果显示,MMP-16是呼吸窘迫综合征患儿并发BPD的危险因素(OR>1,P<0.05),Claudin-18、CC16是保护因素(OR<1,P<0.05);绘制受试者工作曲线(receiver operating characteristic curve,ROC)曲线,结果显示,MMP-16、Claudin-18、CC16评估呼吸窘迫综合征患儿并发BPD的AUC均>0.7,具有一定评估价值,联合评估价值更高(AUC=0.902)。
结论 无创经皮血气+体位管理+保护性通气可改善降低急性呼吸窘迫综合征患儿MMP-16水平,升高Claudin-18、CC16水平,上述3项指标变化与BPD的发生密切相关。


关键词: 呼吸窘迫综合征, 新生儿, 血气监测, 经皮, 体位

Abstract: Objective To investigate the effects of noninvasive transcutaneous blood gas+postural management+protective ventilation intervention for neonatal respiratory distress syndrome (NRDS) on matrix metalloproteinase-16 (MMP-16), Claudin-18, and Clara cell secretory protein 16 (CC16) in children, and to analyze the correlation between the above indicators and bronchopulmonary dysplasia (BPD). 
Methods A total of 106 neonates with NRDS were selected prospectively for the study, and all children received noninvasive transcutaneous blood gas+postural management+protective ventilation intervention. The changes of MMP-16, Claudin-18, and CC16 in neonates were observed before and after intervention. The incidence of BPD in neonates was calculated within two weeks of intervention, and children were divided into BPD group and non-BPD group, to analyze the relationship between MMP-16, Claudin-18, CC16 and BPD. 
Results After intervention, MMP-16 levels were lower than those before intervention, while Claudin-18 and CC16 levels were higher than those before intervention (P<0.05). BPD occurred in 57 of 106 children with NRDS, accounting for 53.77%. Compared with the non-BPD group, MMP-16 levels were higher and Claudin-18 and CC16 levels were lower in the BPD group (P<0.05). By point-biserial correlation analysis, the results showed that MMP-16 was positively correlated with the occurrence of BPD (r=0.542, P<0.05), and Claudin-18 and CC16 levels were negatively correlated with the occurrence of BPD (r=-0.526, -0.639, P<0.05). By logistic regression analysis, the results showed that MMP-16 was a risk factor for the complication of BPD in children with NRDS (OR>1, P<0.05), and Claudin-18 and CC16 were protective factors (OR<1, P<0.05). Receiver operating characteristic (ROC) curve was drawn, which showed that the area under the ROC curve (AUC) of MMP-16, Claudin-18 and CC16 for the assessment of BPD in children with NRDS was all >0.7, showing assessment value. The value of the combined assessment was higher (AUC=0.902). 
Conclusion Noninvasive transcutaneous blood gas+postural management+protective ventilation can improve the reduction of MMP-16 levels and increase Claudin-18 and CC16 levels in children with acute respiratory distress syndrome, and the changes of the above three indexes are closely related to the occurrence of BPD. 


Key words: respiratory distress syndrome, neonates, blood gas monitoring, transcutaneous, posture